国: オーストラリア
言語: 英語
ソース: APVMA (Australian Pesticides and Veterinary Medicines Authority)
LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE; SPECTINOMYCIN AS SPECTINOMYCIN SULFATE
ZOETIS AUSTRALIA PTY LTD
lincomycin as HCl(50mg/mL)+spectinomycin as sulfate(100mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE ANTIBIOTIC Active 50.0 mg/ml; SPECTINOMYCIN AS SPECTINOMYCIN SULFATE ANTIBIOTIC Active 100.0 mg/ml
100mL Vial
VM - Veterinary Medicine
ZOETIS AUSTRALIA
CAT | DOG | PIGS | POULTRY BROILERS (MEAT FOR HUMAN CONSUM) | BITCH | BOAR | CASTRATE | CAT - QUEEN | CAT - TOM | CHICKENS | CHO
ANTIBIOTIC & RELATED
CHRONIC RESPIRATORY DISEASE | ENTERITIS ASSOCIATED WITH E.COLI | ESCHERICHIA COLI (E. COLI) | INFECTIONS OF THE RESPIRATORY TRACT | INFECTIONS OF THE SKIN | INFECTIONS OF THE URINARY TRACTS | INFECTIONS OF UPPER RESPIRATORY TRACT | LOCALISED INFECTIONS | MYCOPLASMA GALLISEPTICUM | MYCOPLASMAL PNEUMONIA | SECONDARY INFECTION | SWINE DYSENTERY | ABSCESSES | ACUTE RESPIRATORY INFECTIONS | ANAL SACCULITIS | BRONCHISEPTICA | BRONCHITIS | CHRONIC RESPIRATORY DISEASE (C | ESCHERICHIA COLI | FUNGAL | GINGIVITIS | GRAM NEGATIVE BACTERIA | GRAM POSITIVE BACTERIA | GROUP D STREPTOCOCCUS | INCLUDING B-LACTAMASE PRODUCIN | INFECTIOUS SINUSITIS | KLEBSIELLA SPP. | PHARYNGITIS | PNEUMONIA | POST-PARTURIENT INFECTIONS | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | PYODERMA | SECONDARY BACTERIAL INFECTIONS | SECONDARY BACTERIAL INVADERS | SECONDARY INFECTION TO VIRUS | SEPTICAEMIA | STAPHYLOCOCCUS SPP. | TONSILLITIS | YEAST
Poison schedule: 4; Withholding period: TREATMENT OF INFECTIONS IN PIGS AND BR OILER CHICKENS CAUSED BY ORGANISMS SENS ITIVE TO THE ACTION OF LINCOMYCIN AND/O R SPECTINOMYCIN. WHP: MEAT: Do not use less than the following periods before slaughter for human consumption: pigs 2 1 days broiler chickens 10 days. ES I: This product does not have an ESI e stablished. For advice on the ESI con tact the manufacturer on 1800 814 883 before using this product.; Host/pest details: CAT: [INFECTIONS OF THE URINARY TRACTS, INFECTIONS OF UPPER RESPIRATORY TRACT, LOCALISED INFECTIONS, SECONDARY INFECTION]; DOG: [INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE SKIN, INFECTIONS OF THE URINARY TRACTS, SECONDARY INFECTION]; PIGS: [ENTERITIS ASSOCIATED WITH E.COLI, MYCOPLASMAL PNEUMONIA, SWINE DYSENTERY]; POULTRY BROILERS (MEAT FOR HUMAN CONSUM): [CHRONIC RESPIRATORY DISEASE, ESCHERICHIA COLI (E. COLI), MYCOPLASMA GALLISEPTICUM]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [INFECTIONS OF THE URINARY TRACTS, INFECTIONS OF UPPER RESPIRATORY TRACT, LOCALISED INFECTIONS, SECONDARY INFECTION]; DOG: [INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE SKIN, INFECTIONS OF THE URINARY TRACTS, SECONDARY INFECTION]; PIGS: [ENTERITIS ASSOCIATED WITH E.COLI, MYCOPLASMAL PNEUMONIA, SWINE DYSENTERY]; POULTRY BROILERS (MEAT FOR HUMAN CONSUM): [CHRONIC RESPIRATORY DISEASE, ESCHERICHIA COLI (E. COLI), MYCOPLASMA GALLISEPTICUM]; For the treatment of infections in pigs, broiler chickens, dogs and cats caused by organisms sensitive to the action of lincomycin and/or spectinomycin.contraindicated in animals previously found to be hypersensitive to either antibiotic or the combination. Linco-Spectin should not be administered to animals with known pre-existing monilial infections.
Registered
2023-07-01
PFIZER ANIMAL HEALTH Product Name: LINCO-SPECTIN "" ANTIBIOTIC INJECTABLE SOLUTION Date: 1 November 2011 Page 1 of 9 Product Size: 100 mL Description: Composite Label File number: LAB0807 - Linco-Spectin Ant ibiotic Version: 2 Injectable Soluti on - Nov 11 (highlighted).doc Reason: Category 14- Addition of In use shelf life, ESI statement and ot her updates to comply with current labelling requirements. T ex t above this line and in italics between parallel lines is not included in the label copy. IMMEDIATE CONTAINER- Main Panel PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY LINCO-SPECTIN® Antibiotic Injectable Solution LINCOMYCIN .. ... .. .. .. .. 50 mg/ml (as lincomycin hydrochloride) SPECTINOMYCIN ..... 1 00 mg/ml (as spectinomycin sulphate) 100 mL IMMEDIATE CONTAINER- Right Panel READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT DIRECTIONS FOR USE Dosage and Administration RLP APPROVED Use the contents within 28 days of first broaching of the vial. Discard the unused po rtion. WITHHOLDING PERIODS: MEAT: DO NOT USE less than the following periods before slaughter for human consumption . Pigs Broiler chickens 21 days 10 days TRADE ADVICE: ESI not established. FIRST AID: If poisoning occurs, co ntact a doctor or Poiso ns Information Centre. Pho ne Australia 131 126. APVMA Approval No. 38692/53703 Pfizer Animal Health A division of Pfizer Australia Pty Ltd 38-42 Wha rf Road West Ryde NSW 2114 Store below 30 °C (Room Temperature) Batch: Ex ir : PRIMARY PACK- Front Panel Infopest Verified PFIZER ANIMAL HEALTH Product Name: LINCO-SPECTIN "" ANTIBIOTIC INJECTABLE SOLUTION Date: 1 November 2011 Page 2 of 9 Product Size: 100 mL Description: Composite Label File number: LAB0807 - Linco-Spectin Antibiotic Version: 2 Injectable Solution- Nov 11 (highlighted). doc Reason: Category 14- Addition of In use shelf life, ESI statement and other updates to comply with current labelling requirements. Text above this line and in italics between parallel lines is not included in the label cop 完全なドキュメントを読む
PRODUCT NAME: LINCO-SPECTIN ® ANTIBIOTIC INJECTABLE SOLUTION PAGE: 1 OF 5 THIS REVISION ISSUED: APRIL, 2010 MATERIAL SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: (02)9850 3333 SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: (02) 9850 3333 Fax: (02) 9850 3399 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 SUBSTANCE: Active ingredients are antibiotics. TRADE NAME: LINCO-SPECTIN ® ANTIBIOTIC INJECTABLE SOLUTION PFIZER MSDS CODE: 092 PRODUCT USE: Antibiotic vaccine for use as described on the product label. CREATION DATE: JANUARY, 2005 THIS VERSION ISSUED: APRIL, 2010 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Colourless to slightly yellow solution. May have a slight haze. ODOUR: No data MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S Repeated overexposure to lincomycin may cause abdominal cramps, diarrhoea and colitis. This may begin several weeks after exposure has ceased. Some hematopoietic effects have been reported with the use of lincomycin. Hypersensitivity reactions have been reported in people known to be sensitive to penicillin. Rare instances of erythema multiforme, some resembling Stevens-Johnsone Syndrome, have been associated with lin 完全なドキュメントを読む